Revelations of a sweeping electronic surveillance operation by the FDA has interesting implications for wiretapping and surveillance policy.
The FDA recently approved a new HIV/AIDS drug intended to help prevent at-risk people from attaining the virus. Health professionals insist the drug will only be successful in combination with other preventative methods.
To date, over 1 million Americans have contacted the FDA, asking for the agencies support in GMO labeling. Far more than any petition to the FDA in history.
The senate failed to pass a bill last month that would have required the labeling of all GMOs by vote of 26 to 73. Currently there are more than 40 industrialized countries which require the labeling of GMOs.
GlaxoSmithKline LLC pleads guilty this week to a $3 billion fine for health care fraud charges, including illegally promoting unapproved drugs as well as failing to disclose the drugs safety precautions.
After numerous grassroots movements to get genetically modified food labeled, the Senate failed to pass an amendment that would allow states to do so.
The idea of a regulatory cap has been kicking around in conservative policy circles, but it has now gained an important adherent in the form of Governor Mitt Romney. He pledges to impose “a regulatory cap of zero dollars on all federal agencies.”
